Senior insider sale
Chief Medical Officer* at IMMUNOVANT, INC. — senior position signals high conviction
$3.87M
163.58K shares
What this filing means
GEFFNER MICHAEL plans to sell 163.58K shares of IMMUNOVANT, INC. valued at approximately $3.87M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/10/2026ACC: 0001950047-26-001125
Officer· Chief Medical Officer*
Since Jan 2024
163.58K
Shares to sell
$3.87M
Approx. market value
5.80K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
1/17/2026
3.77KRestricted Stock
Not Applicable
1/2/2026
2.03KTotal acquired5.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2026 | Restricted Stock Not Applicable | 3.77K | — |
1/2/2026 | Restricted Stock Not Applicable | 2.03K | — |
| Total | 5.80K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
2.48K
Market value
$64.6K
1/21/2026
—Completed
Units to sell
1.41K
Market value
$37.3K
1/7/2026
—Completed
Units to sell
50K
Market value
$1.19M
11/26/2025
—Completed
Units to sell
103.90K
Market value
$2.43M
11/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.80K
Market value
$155.2K
2/10/2026
Total
Units
163.58K
Value
$3.87M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/21/2026 | 2.48K | $64.6K | — | Completed |
1/7/2026 | 1.41K | $37.3K | — | Completed |
11/26/2025 | 50K | $1.19M | — | Completed |
11/25/2025 | 103.90K | $2.43M | — | Completed |
| Planned — Approximate Date | ||||
2/10/2026 | 5.80K | $155.2K | NASDAQ | Planned |
| Total | 163.58K | $3.87M | ||